Global Home Global Home  
 
 

 

 

Press Releases

= Add Release to Briefcase

DATE

TITLE

 
Oct 3, 2017 Sonoma Pharmaceuticals Announces U.S. Commercialization of Loyon® for Relief of Scaling, Burning and Itching Associated with Various Dermatoses Including Seborrhea and Seborrheic Dermatitis PDF 20.1 KB Add to Briefcase
 
 
Sep 14, 2017 Sonoma Pharmaceuticals Announces Commercialization of MicrocynAH® Animal Healthcare Products in Japan PDF 20.7 KB Add to Briefcase
 
 
Aug 8, 2017 Sonoma Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 PDF 41.9 KB Add to Briefcase
 
 
Jul 25, 2017 Sonoma Pharmaceuticals Announces Fiscal First Quarter 2018 Financial Results and Conference Call PDF 16.9 KB Add to Briefcase
 
 
Jul 13, 2017 CORRECTING and REPLACING -- Sonoma Pharmaceuticals Announces Record Quarterly Prescription Data PDF 21.5 KB Add to Briefcase
 
 
Jul 13, 2017 Sonoma Pharmaceuticals Announces Record Quarterly Prescription Data PDF 21.1 KB Add to Briefcase
 
 
Jun 28, 2017 Sonoma Pharmaceuticals Announces Publication of Consensus Report Describing Celacyn's (Hypochlorous Acid) Impact on Post-Procedure Treatment and Scar Prevention PDF 21.2 KB Add to Briefcase
 
 
Jun 20, 2017 Sonoma Pharmaceuticals Announces Two Singapore Approvals for Microcyn® (hypochlorous acid) for the Treatment of Atopic Dermatitis and Hypertrophic /¬†Keloid Scars PDF 19.8 KB Add to Briefcase
 
 
Jun 5, 2017 Sonoma Pharmaceuticals Reports Financial Results for Fourth Quarter and Fiscal Year 2017 PDF 49.6 KB Add to Briefcase
 
 
Jun 2, 2017 Sonoma Pharmaceuticals Announces Fiscal Year/Fourth Quarter 2017 Financial Results and Conference Call PDF 16.9 KB Add to Briefcase
 

Showing 1-10 of 65

Page: 1 2 3 ... 7

 Next 10